Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Lionsgate Studios Corp. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2021
FY2022
FY2023
FY2025
FY2025
FY2026
Revenue
3,084
2,450
2,585
2,632
General and administrative
387
385
358
398
Operating income
140
-14.5
-18.1
97.1
Interest expense
163
247
262
260
Interest income
6.4
18.5
15
17.9
Pre-tax income
5.4
-240
-277
-159
Income tax
14.3
21.7
17.2
16.2
Income from continuing operations
-248
-283
-182
Net income to minority interests
-8.6
-13.4
-11.6
6.3
Net income
-18.9
-188
-2,010
-1,103
-362
-198
EBITDA
158
1.1
-0.3
115
EPS, basic
0.00
-4.58
-1.43
-0.70
EPS, diluted
0.00
-4.58
-1.43
-0.70
Shares, basic (weighted)
23.2
244
249
285
Shares, diluted (weighted)
23.2
244
249
285
Balance sheet
FY2021
FY2022
FY2023
FY2025
FY2025
FY2026
Cash and equivalents
270
251
277
213
342
Receivables
689
586
785
Other current assets
373
362
362
Total current assets
1,372
1,236
1,489
Property, plant and equipment
37.3
34.1
34.9
Lease right-of-use assets
344
294
263
Goodwill
796
811
809
847
Intangible assets
25.7
20.8
25.8
Other non-current assets
853
827
761
Total assets
5,103
6,822
5,327
Accounts payable
247
257
213
Accrued liabilities
282
229
354
Deferred revenue
171
202
370
Short-term debt
860
134
162
Total current liabilities
3,642
3,467
3,047
Long-term debt
923
1,839
1,778
Lease liabilities
330
291
261
Other non-current liabilities
453
417
308
Total liabilities
6,130
7,081
6,377
Total debt
1,783
1,973
1,940
Retained earnings
-1,249
-3,534
-3,733
Other comprehensive income
96.7
72.6
43.4
Shareholders' equity
-1,152
-265
-1,193
Minority interests
2.2
-88
29.4
Total equity
-260
786
-311
-353
-1,164
Total liabilities and equity
5,103
6,822
5,327
Cash flow statement
FY2021
FY2022
FY2023
FY2025
FY2025
FY2026
Net income
-18.9
-188
-8.9
-1,116
-374
-192
Depreciation and amortization
17.9
15.6
17.8
17.6
Stock-based compensation
73.4
70.2
57
78
Deferred income tax
1.6
0.6
-0.4
2.9
Change in receivables
-137
96.3
183
28.7
Change in payables
57.4
-36.7
-115
-72.5
Cash from operations
346
397
-166
24.8
Capital expenditures
-6.5
-9.9
-13.5
-13.4
Cash from investing
31.3
-377
-53
-8.7
Debt issued
1,523
3,145
4,235
2,950
Stock issued
0.5
0.7
0.4
Cash from financing
-395
39.6
144
111
Exchange rate effect
-1.8
0.8
-3.1
Net change in cash
-17.1
59.6
-74.8
127
Free cash flow
340
387
-180
11.4
Interest paid
138
222
241
269
Income taxes paid
14.3
22.1
20.1
14.1
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $10.85 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Operating margin
4.6%
Operating income / revenue.
EBITDA margin
5.2%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-3.3%
Pre-tax income / revenue.
Net margin
-4.1%
Net income / revenue.
FCF margin
3.4%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
3.8%
Cash from operations / revenue.
Return on assets (ROA)
-2.2%
Net income / average total assets.
Return on invested capital (ROIC)
38.1%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue
4.0%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.4%
Capital expenditures / revenue.
D&A / revenue
0.6%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
1.8%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-5.1%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 3y
-11.4%
Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 3y
-10.0%
Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 3y
-58.5%
Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 3y
-67.7%
Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
-21.9%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
14.7%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
130.7%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.44x
Current assets / current liabilities.
Quick ratio
0.33x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.13x
(Cash + short-term investments) / current liabilities.
Debt / assets
35.7%
Total debt / total assets.
Liabilities / assets
119.8%
Total liabilities / total assets.
Net debt
$1.48B
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
9.78x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.41
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$9.89
Revenue / diluted weighted shares.
FCF per share
$0.33
Free cash flow / diluted weighted shares.
Operating cash flow per share
$0.38
Cash from operations / diluted weighted shares.
Book value per share
-$4.12
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
1.12x
Market cap / revenue.
P/FCF
33.2x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
29.4x
Market cap / cash from operations, when positive.
EV/Sales
1.63x
Enterprise value / revenue.
EV/EBIT
35.3x
Enterprise value / operating income, when both are positive.
EV/EBITDA
31.2x
Enterprise value / EBITDA, when both are positive.
EV/FCF
48.5x
Enterprise value / free cash flow, when both are positive.
FCF yield
3.0%
Free cash flow / market cap.
Earnings yield
-3.7%
Net income / market cap (the inverse of P/E).
What was Lionsgate Studios Corp.'s revenue in fiscal 2026?
Lionsgate Studios Corp. reported revenue of $2.63B for fiscal 2026, 1.8% higher than the year before.
Was Lionsgate Studios Corp. profitable in fiscal 2026?
No. It reported a net loss of $198.3M.
How much free cash flow did Lionsgate Studios Corp. generate in fiscal 2026?
Cash from operations of $24.8M minus capital expenditures of $13.4M left free cash flow of $11.4M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.